
Albert David Ltd Valuation Shifts Signal Attractive Entry Point Amid Sector Challenges
2026-11-17 08:01:48Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, prompting an upgrade in its investment grade from Hold to Buy. With a current price of ₹778.90 and a price-to-earnings (P/E) ratio of 15.46, the stock now presents an attractive valuation compared to its historical averages and peer group, signalling a potential opportunity for investors seeking value in a competitive industry.
Read More
Albert David Ltd is Rated Hold by MarketsMOJO
2026-11-11 10:10:52Albert David Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 October 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 11 November 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Albert David Ltd Valuation Shifts to Attractive Amid Sector Challenges
2026-11-05 08:02:26Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed returns and sector-wide valuation pressures, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.
Read More
Albert David Ltd is Rated Hold by MarketsMOJO
2026-10-30 10:10:48Albert David Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Albert David Ltd is Rated Hold by MarketsMOJO
2026-10-19 10:10:41Albert David Ltd is rated Hold by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Albert David Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals
2026-10-08 08:16:10Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 7 October 2026. This revision reflects a nuanced assessment across quality, valuation, financial trends, and technical indicators, signalling a more cautious stance despite recent strong quarterly earnings and a net-debt-free balance sheet.
Read More
Albert David Ltd Upgraded to Buy on Strong Financial and Technical Improvements
2026-09-29 08:40:28Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 28 Sep 2026. This upgrade reflects significant improvements across technical indicators, financial performance, valuation metrics, and overall quality scores, positioning the stock favourably against its peers and broader market benchmarks.
Read More
Albert David Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
2026-09-24 08:23:06Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 23 September 2026. This adjustment reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, despite the company’s strong recent profit growth and market-beating returns.
Read More
Albert David Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals
2026-09-08 08:51:46Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 7 September 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust quarterly earnings and a net-debt-free balance sheet, evolving technical indicators and valuation premiums have tempered enthusiasm among analysts.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
18-Nov-2026 | Source : BSENewspaper publication dated 18th November 2026 in Financial Express(All India Editions) and Aajkal (Bengali Newspaper) about 5th Reminder for Special Window for Re-lodgment of physical Transfer
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2026 | Source : BSENewspaper Publication-Regarding Extract of Unaudited Financial Results for the quarter and half year ended 30th September 2026
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026
12-Nov-2026 | Source : BSEUnaudited Financial Results for the quarter and half year ended 30th September 2026
Corporate Actions
No Upcoming Board Meetings
Albert David Ltd has declared 50% dividend, ex-date: 30 Jul 26
No Splits history available
No Bonus history available
No Rights history available